Showing results (1-10 of 264) with videos related to
Sort By:
Pageof 27
Pediatric Blood & Cancer|July 27, 2019
Second malignancies in patients treated for Ewing sarcoma: A systematic reviewJennifer Caruso, David S Shulman, Steven G DuBoisPaediatric Drugs|January 23, 2020
The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric CancersDavid S Shulman, Steven G DuBoisEuropean Journal of Cancer (Oxford, England : 1990)|April 1, 2019
Timing of first-in-child trials of FDA-approved oncology drugsDylan V Neel, David S Shulman, Steven G DuBoisPediatric Blood & Cancer|January 8, 2019
Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsiesSamuel D Abbou, David S Shulman, Steven G DuBois, et al.Pediatric Blood & Cancer|November 21, 2020
Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic reviewKevin M Campbell, David S Shulman, Holcombe E Grier, et al.Cancer Medicine|May 1, 2020
Sponsorship of oncology clinical trials in the United States according to age of eligibilityDylan V Neel, David S Shulman, Clement Ma, et al.JCO Precision Oncology|December 23, 2024
Targeted-Agent Continual Reassessment Method: A Novel Bayesian Enrichment Design for Phase I Trials of Molecularly Targeted TherapiesClement Ma, David S Shulman, Hasan Al-Sayegh, et al.Pediatric Blood & Cancer|December 1, 2020
Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysisLenka A Ilcisin, Clement Ma, Katherine A Janeway, et al.Pediatric Blood & Cancer|September 5, 2020
Landscape of phase 1 clinical trials for minors with cancer in the United StatesJaclynne H Nader, Dylan V Neel, David S Shulman, et al.Cancer Medicine|December 16, 2024
Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric OncologyHannah E Olsen, Pei-Chi Kao, Caleb Richmond, et al.Pageof 27